newsfilter
← Latest News
PR Newswire·

Evofem Biosciences Commends Tri-Agencies for Clarifying that Contraceptives Must be Covered at No Cost to Individuals

SAN DIEGO, July 29, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ:EVFM), a women's healthcare company, today commended the U.S. Department of Health and Human Services, alongside the Departments of Labor and of the Treasury ("the Tri-Agencies"),